LLY•benzinga•
Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential
Summary
Piper Sandler initiates coverage of Nektar Therapeutics, citing REZPEG's Treg-focused action as a potential breakthrough for Alopecia areata treatment.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 4, 2024 by benzinga